Apr 14, 2021 / 06:15PM GMT
James Wu - Needham & Company, LLC - Associate on Biotech Equity Research team
Good afternoon, everyone, and thanks for joining us at the 20th Annual Needham Healthcare Conference. My name is James Wu, and I'm associate on the Biotech Equity Research team here at Needham & Company. And it's my pleasure to introduce the next presenting company, Gamida Cell, an exciting company in the cell therapy space. Today, I'm joined by the company's CEO, Julian Adams; and Chief Operating and Chief Commercial Officer, Michele Korfin.
(Operator Instructions) And with that, I'll turn it over to you, Julian.
Julian Adams - Gamida Cell Ltd. - CEO & Director
Thank you, James, and thank you to Needham for inviting us to this conference. I want to also thank all the listeners who are tuning in. And Michele and I will be tag tuning this presentation. But first, there's some forward-looking statements that you can briefly review. And for further details, please consult our SEC filings.
At Gamida cell, we are working very hard in making great progress to
Gamida Cell Ltd at Needham Healthcare Conference (Virtual) Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers